Nickel KB, Wallace AE, Warren DK, Ball KE, Mines D, Fraser VJ, Olsen MA. Modification of claims-based measures improves identification of comorbidities in non-elderly women undergoing mastectomy for breast cancer: a retrospective cohort study. BMC Health Serv Res. 2016 Aug 16;16(a):388. doi: 10.1186/s12913-016-1636-7
Olsen MA, Nickel KB, Margenthaler JA, Fox IK, Ball KE, Mines D, Wallace AE, Colditz GA, Fraser VJ. Development of a risk prediction model to individualize risk factors for surgical site infection after mastectomy. Ann Surg Oncol. 2016 Aug;23(8):2471-9. doi: 10.1245/s10434-015-5083-1
Mines D, Gu Y, Kou TD, Cooper GS. Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):111-8. doi: 10.1002/pds.2057
Cooper G, Mines D, Gu Y. Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Presented at the 24th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; 2008. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2008 Aug; 17(S1):S110-1.
Mines DI, Novelli LA, Yu H. Lymphoma risk in patients with rheumatoid arthritis who received 2 or more disease modifying anti-rheumatic drugs (DMARDs): a retrospective cohort study in the GPRD. Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Aug; 14(S2):S30.